Advances in research
RSS feedAdvances in limb-girdle muscular dystrophies – 2025
This document presents a selection of limb-girdle muscular dystrophy research news stories from the past year (ongoing observational studies and clinical trials, scientific publications, events, etc.). Access the document Advances in limb-girdle muscular dystrophies – 2025
Advances in Duchenne muscular dystrophy and Becker muscular dystrophy – 2025
This document presents a selection of Duchenne muscular dystrophy and Becker muscular dystrophy research news stories from the past year (ongoing observational studies and clinical trials, scientific and medical publications, etc.). Access the document Advances in Duchenne muscular dystrophy and Becker muscular dystrophy – 2025
Advances in myotonic dystrophy type 1 – 2025
This document presents a selection of myotonic dystrophy type 1 (DM1) research news stories from the past year (ongoing observational studies and clinical trials, scientific and medical publications, etc.). Access the document Advances in myotonic dystrophy type 1 – 2025
Advances in myasthenia gravis – 2025
This document presents a selection of myasthenia gravis research news stories from the past year (ongoing observational studies and clinical trials, scientific and medical publications…). Access the document Advances in myasthenia gravis – 2025
Advances 2024 in limb-girdle muscular dystrophies
This document presents limb-girdle muscular dystrophy research news from the past year (ongoing observational studies and clinical trials, scientific and medical publications, etc.). As the name suggests, limb girdle muscular dystrophies (LGMD) affect the “limb girdle” muscles. Symptoms generally appear before the age of 30, with slow progression and no facial muscle involvement. Common symptoms … [Read more]
Advances in congenital muscular dystrophies – June 2024
Apparent at birth or in the first few months of life, congenital muscular dystrophies (CMD) are a group of very diverse, rare diseases characterised by progressive muscle weakness in the trunk and limbs. They may also affect other organs such as the heart, brain and eyes. Common symptoms are muscle weakness with hypotonia causing impaired … [Read more]
Advances in myotonic dystrophy type 1 – June 2024
This disease, which is also known as Steinert disease, mainly affects the muscles but can also impact other organs to a greater or lesser extent. DM1 is a “multisystem” disorder, meaning it affects several different organs (muscles, the heart, the respiratory system, the digestive system, the endocrine system and the nervous system). Muscles decrease in … [Read more]
Advances in myotonic dystrophy type 2Â – June 2024
DM2 mainly affects the muscles but can also impact other organs to a greater or lesser extent. It is very similar to another more common neuromuscular disease called myotonic dystrophy type 1 (DM1). Muscles decrease in volume, become weak (dystrophy) and have difficulty relaxing after they contract (myotonia). DM2 is a “multisystem” disorder, meaning it … [Read more]
Advances in Charcot-Marie-Tooth disease – June 2024
Charcot-Marie-Tooth disease is a group of genetic diseases that cause damage to the peripheral nerves (nerves that connect the spinal cord to muscles and sensory organs) of the arms and legs (neuropathy). It is also known as hereditary motor and sensory neuropathy (HMSN). Common symptoms are muscle weakness and wasting in the legs (feet and … [Read more]
Advances in congenital myopathies
Congenital myopathies are a heterogenous group of rare diseases characterised by structural abnormalities in muscle fibres which are most often detected at a young age. These abnormalities lead to muscle weakness (hypotonia and impaired motor skills) which generally manifests at birth or during the first few months of life (“congenital”). This document, presents research news … [Read more]
